Evelo Biosciences, Inc. (EVLO)

Trade EVLO now with
1/28/2021 9:39:17 PM Evelo Biosciences Prices Underwritten Public Offering Of 4.50 Mln Shares At $15.00/shr
1/20/2021 7:06:43 AM Evelo Biosciences Announces New Positive Confirmatory Data From Phase 1b Trial Of EDP1815 In Atopic Dermatitis
12/9/2020 7:09:22 AM Evelo Biosciences Reports Positive Topline Clinical Data In Phase 1b Trial Of EDP1815 In Atopic Dermatitis
12/3/2020 7:13:21 AM Evelo Biosciences Completes Enrollment To Interim Target In Phase 2 Trial Of EDP1815 For Psoriasis
10/14/2020 7:13:43 AM Evelo Completes Enrollment In Phase 1b Clinical Trial Cohort Evaluating EDP1815 In Atopic Dermatitis
10/13/2020 7:10:40 AM Evelo Biosciences Treats First Patients In Phase 2 Dose-Ranging Trial Of EDP1815 For Psoriasis
9/14/2020 7:13:10 AM Evelo Biosciences Appoints Julie Carretero As Chief People Officer
7/1/2020 7:11:49 AM Evelo Biosciences To Present Clinical Data From Phase 1/2 Trial Of EDP1503 At ESMO World Congress
6/22/2020 2:17:35 AM Evelo Biosciences: EDP1815 To Be Included In The TACTIC-E Clinical Trial
4/15/2020 7:04:23 AM Evelo Biosciences Appoints Neil Graham As Chief Development Officer
12/5/2019 7:15:02 AM Evelo Biosciences Appoints Juan Andres To Its Board
9/17/2019 7:09:16 AM Evelo Biosciences Appoints David Epstein As Chairman Of Board
9/17/2019 7:02:53 AM Evelo Biosciences Names David Epstein Chairman Of Its Board